Oligonucleotides offer enormous potential for manipulating gene function in cells and, as
such, constitute a promising new class of pharmaceutical agents. Oligonucleotides that form
triple helices (triplexes) at specific DNA sequences in defined genes can be used to reduced
transcription selectively, to introduce site-specific mutations or to stimulate gene-specific
targeted recombination.